Trends in innovative drug development in China
Xian Su(National Medical Products Administration), Yimin Cui(Peking University), Nan Zhao(Army Medical University), Haixue Wang(National Medical Products Administration), Tao Wang(Kunming University of Science and Technology)
Cited by 51
Related Papers
H3N2 Mismatch of 2014–15 Northern Hemisphere Influenza Vaccines and Head-to-head Comparison between Human and Ferret Antisera derived Antigenic Maps
|Scientific Reports|2015|161
Engineered probiotic ameliorates ulcerative colitis by restoring gut microbiota and redox homeostasis
|Cell Host & Microbe|2024|156
Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism
|Nature Communications|2014|151
USP28 Serves as a Key Suppressor of Mitochondrial Morphofunctional Defects and Cardiac Dysfunction in the Diabetic Heart
|Circulation|2023|127
Community-wide evaluation of methods for predicting the effect of mutations on protein-protein interactions
|Proteins Structure Function and Bioinformatics|2013|93